Capreomycin sulfate(CAS: 1405-37-4)

Capreomycin sulfate (CAS: 1405-37-4) is subject to regulatory guidelines such as the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), registration under the European Union's REACH regulation, and requirements by the U.S. FDA and EPA. This includes proper labeling, storage, and handling practices to ensure worker safety and environmental protection.

Alternatives to Capreomycin sulfate (CAS: 1405-37-4) in synthesis include other aminoglycoside antibiotics like amikacin, kanamycin, and streptomycin. These alternatives offer similar antimicrobial properties but may differ in terms of efficacy, toxicity, and resistance patterns.

The market for Capreomycin sulfate (CAS: 1405-37-4) is experiencing steady growth due to its effectiveness against multidrug-resistant tuberculosis. Ongoing research focuses on optimizing its therapeutic index and exploring its use in combination therapies. Market dynamics include increased demand from emerging markets and the development of new formulations.

Waste containing Capreomycin sulfate (CAS: 1405-37-4) should be collected, stored, and disposed of in accordance with hazardous waste regulations. Proper handling includes neutralization to reduce toxicity, followed by incineration or professional waste disposal to ensure environmental safety and compliance with local and international environmental protection standards.